Wednesday - January 7, 2026
International Association for the Study of Lung Cancer: Neoadjuvant Atezolizumab Meets Safety Criteria
September 13, 2021
DENVER, Colorado, Sept. 13 (TNSRes) -- The International Association for the Study of Lung Cancer issued the following news release on Sept. 12, 2021:

Neoadjuvant cisplatin and pemetrexed plus atezolizumab followed by surgical resection and maintenance atezolizumab met safety criteria, according to research presented today in OA13: Topics in Pleural Mesothelioma at the IASLC 2021 World Conference on Lung Cancer.

Dr. Anne Tsao of MD Anderson Cancer Center in Houston and . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products